Biotech/MedTech
October 2024

ResusRight

About ResusRight - For safer birth

ResusRight was founded by a group of clinicians and engineers with a shared mission to create technology that empowers clinicians to deliver high-quality care at birth. ResusRight’s first product was designed to revolutionise the way clinicians train for neonatal resuscitation by giving real-time, objective insight into mask technique, volume delivery and ventilatory rate.

ResusRight is also conducting R&D into a clinical monitor to assist during resuscitation at birth, to support clinicians by ensuring every baby gets the best start to life.

What is the company focused on now?

While continuing to develop its neonatal resuscitation technology, ResusRight was also working on the transaction of an asset of strategic value to the company.

With a lot of the team’s focus and resources allocated to the transaction, the company faced the challenge of balancing it with its R&D efforts and day-to-day operations.

Why did they seek an R&D Loan? What did it help them achieve?

With their R&D efforts making up a significant portion of their expenses, they needed additional working capital to ensure the business had the capital available to fund the daily running of the business. Raising more equity capital wasn’t an ideal solution at the time, as they didn’t want to dilute ownership. Knowing their R&D refund was due in six months, they turned to Kashcade to access it early. The R&D Loan allowed them to access the capital they needed immediately, ensuring their operations could continue without interruption while they pursued their strategic goal.

Stop waiting on the ATO.Access your R&D refund in 48 hours.

Like Resus Right, you can bring forward your RDTI refund - no equity dilution, no monthly repayments, no drawn-out process.

Get funded now → Calculate your funding

What was your experience like with Kashcade?

Our experience with Kashcade was seamless. The application process was extremely simple and took very little time from our management team. At a time when we were focused on a strategic transaction, this was critical.

Kashcade’s R&D Loan was quick, and came without the typical complexities of raising capital, helping us maintain focus on what mattered most.
Matt Boustred, Co-founder & CEO

I was incredibly impressed with how fast and seamless the process was. I wouldn’t hesitate to work with the Kashcade team in the future for any financing needs

About Kashcade

Kashcade is Australia's top-rated R&D lender, helping Australian companies bring forward future claimable R&D Tax Incentive refunds so they can access cash now, not months after tax time. Kashcade's cost-effective pricing, 24–48 hour funding promise, and quick and easy application process are why CEOs and CFOs choose us.

We've deployed over $150 million across 250+ customers and have won The Finnies award for 'Excellence in Business Lending' in 2026, and were named finalists in 2025. We've been featured in the Australian Financial Review, Startup Daily, and FinTech Australia. Our team includes former R&D tax advisors, commercial lenders, and lending technology engineers.

Related Case Study

SASS
June 2026

PHM Technology used an R&D facility to take control of their cash flow and keep it healthy now and into the future.

PHM Technology

SASS
March 2026

EncompaaS's multi-drawdown strategy with a Kashcade R&D facility unlocked fast capital without any equity dilution.

EncompaaS

SASS
February 2026

Identitii used a Kashcade R&D facility to plan ahead of growth and access the capital they needed to scale fast.

Identitii